Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Combination safety considerations The combination of AOD 9604 and tirzepatide has not been studied in formal clinical trials
This educational protocol presents a subcutaneous injection approach to maximize bioavailability from the 10 mg vial format
The sweet spot Ive landed on after extensive self-experimentation is a much more conservative signaling-based approach: 1 mg subcutaneously in the morning, 5 days on, 2 days off, cycled 8 weeks on and 8 weeks off
Side effects are uncommon and typically limited to mild injection site reactions
Regular supplementation helps prevent neurological symptoms linked to deficiency
NNMT is more active
US$ 23.87
US$ 28.94
US$ 25.75
US$ 20.06
US$ 20.91
US$ 24.13
US$ 23.30
US$ 22.47
US$ 26.72
US$ 26.72
US$ 24.65
